Program Description
Pneumococcal disease (PD) can lead to serious complications, particularly in high-risk patients and older adults. Vaccines to prevent PD are continually emerging, with new serotypes being included. These new and emerging vaccines provide an opportunity for pharmacists to play a key role in identifying and educating high-risk patients on the role of vaccinations in the prevention of PD. This activity will provide an update on pneumococcal vaccination recommendations from the Advisory Committee on Immunization Practices, with a focus on adult patients. It will also address shared clinical decision-making strategies that can be used by pharmacists in recommending and administering pneumococcal vaccinations. Vaccine hesitancy, strategies to improve vaccination rates, and coadministration with other routine vaccinations will also be discussed.
Target audience: Retail pharmacists
Type of activity: Application
Release date: October 31, 2024
Expiration date: October 31, 2025
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify the risk of pneumococcal disease in patients with chronic conditions
- Explain the Advisory Committee on Immunization Practices guideline recommendations for pneumococcal vaccination
- Implement pharmacy-led strategies to increase pneumococcal vaccination
Jeff Goad, PharmD, MPH
Professor and Associate Dean
Office of Academic Affairs
Chapman University School of Pharmacy
Irvine, California
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-311-H06-P. The activity is available for CE credit through October 31, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Faculty
Jeff Goad, PharmD, MPH, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Valneva, Merck & Co, Inc, Moderna, Inc
Speakers Bureau: Merck & Co, Inc
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Adam C. Welch, PharmD, MBA, FAPhA; Kylie Ferrentino; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms